Juvena CEO, Hanadie Yousef, Explores the Future of the Intersection of Technology and Biology Alongside Silicon Valley Entrepreneurs with Middle East & Northern African roots at the Annual TechWadi Forum
Biocom California Names Juvena CEO Hanadie Yousef as One of Ten Recipients of Its 7th Annual Catalyst Award, Recognizing the Most Inspiring and Driven Minds Sparking Meaningful Change to Human Health
Discussing longevity insights among financial and biotech leaders at the BioFuture Conference, Juvena CEO, Hanadie Yousef, PhD explores the role of secreted proteins in targeting chronic and age-related diseases.
Juvena’s CSO, Dr. O’Connell, was an invited speaker at the 6th Annual Fibrotic Drug Discovery Summit in Nov. 2022 and discussed how decoding stem cell secreted proteins can enable drug discovery for fibrotic degenerative diseases, providing an overview of Juvena’s pulmonary and hepatic programs.
Annual BioFuture 2022 Event Recognizes Juvena CEO Dr. Hanadie Yousef Among Longevity Pioneers Shaping Expectations in Healthcare and Celebrates the Company’s Series A Announcement
Annual BioFuture 2022 Event Recognizes Juvena CEO Dr. Hanadie Yousef Among Longevity Pioneers Shaping Expectations in Healthcare and Celebrates the Company’s Series A Announcement
Juvena Therapeutics is recognized for its transformative science that targets unmet medical needs as well as for the quality of its management team as part of the Emerging Company Showcase at the prestigious Life Sciences Summit.
BioCom California, the leading life science industry organization in California recognizes Juvena’s CEO, Dr. Hanadie Yousef for her achievements, vision and scientific and business accumen in its Life Science Catalyst Awards.
